Express ScriptsPrint Page | Close Window

Investor Information

IR banner

Business Overview

Business Overview
At Express Scripts we believe in practicing pharmacy smarter. We put medicine within reach of tens of millions of people by aligning with our customers, taking bold action and delivering patient-centered care to make better health more affordable and accessible.

Headquartered in St. Louis, Express Scripts provides integrated pharmacy benefit management services, including network-pharmacy claims processing, home delivery pharmacy care, specialty pharmacy care, specialty benefit management, benefit-design consultation, drug utilization review, formulary management and medical and drug data analysis services. Express Scripts also distributes a full range of biopharmaceutical products and provides extensive cost-management and patient-care services.

Stock chart for: ESRX.O.  Currently trading at $71.75 with a 52 week high of $80.02 and a 52 week low of $64.46.
ESRX (Common Stock)
ExchangeNASDAQ (US Dollar)
Change (%) Stock is Down 0.7 (0.97%)
Data as of 01/20/17 4:00 p.m. ET
Refresh quote
Recent Press Releases
Express Scripts Holding Company Announces Fourth Quarter and Full Year 2016 Earnings Conference Call - 01/18/2017 - 11:12 a.m.
ST. LOUIS, Jan. 18, 2017 (GLOBE NEWSWIRE) -- Express Scripts Holding Company (Nasdaq:ESRX) (“Express Scripts”) announced today its intention to release its 2016 fourth quarter and full year financia... 
Express Scripts Holding Company to Present at the J.P. Morgan Healthcare Conference - 01/04/2017 - 11:44 a.m.
ST. LOUIS, Jan. 4, 2017 /PRNewswire/ -- Express Scripts Holding Company (Nasdaq: ESRX) ("Express Scripts") announced today that it will present at the J.P. Morgan Healthcare Conference on Monday, Janu... 
Express Scripts Holding Company Announces 2017 Financial Guidance - 12/14/2016 - 7:00 a.m.
ST. LOUIS, Dec. 14, 2016 /PRNewswire/ -- Express Scripts Holding Company (Nasdaq: ESRX) anticipates achieving adjusted earnings per diluted share1 for 2017 in the range of $6.82 to $7.02, representing... 
Express Scripts Announces Enhancements to Industry Leading SafeGuardRx(SM) Programs - 12/12/2016 - 7:00 a.m.
- Hepatitis Cure Value Program® expands covered treatments to include both Viekira Pak™ and Harvoni® in 2017 - Oncology Care Value Program(SM) expands indication-based management to medications tha... 
Receive E-mail AlertsE-mail Alert Icon
Sign up to receive e-mail alerts whenever Express Scripts Holding Co posts new information to the site. Just enter your e-mail address and click Submit.

Tax Consequences of Express Scripts and Medco Merger

Investor Overview
Learn more about Express Scripts and find corporate and shareholder information.

Data provided by Nasdaq. Minimum 15 minutes delayed.